Daily stock price indexes of selected pharmaceuticals firms 2020-2023

Published by Statista Research Department, Apr 27, 2023
This statistic shows the stock price development of selected companies in the pharmaceuticals industry from January 6, 2020 to April 26, 2023. After developing and distributing effective vaccines against COVID-19, the stock values of BioNTech and Moderna increased substantially during this period. Moderna's stock value increased by close to 1,700 percent between January 2020 and October 2021. Similarly, BioNTech saw its highest valuation in August 2021. In comparison, the stock prices of Pfizer and Roche remained rather stable throughout the period considered.

Daily stock price indexes of selected pharmaceuticals companies from January 6, 2020 to April 26, 2023

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2023

Region

Worldwide

Survey time period

January 6, 2020 to April 26, 2023

Supplementary notes

Index base: 100 = January 6, 2022

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " BioNTech "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you BioNTech

Overview

5

Key figures

5

Competitors

6

COVID-19 vaccine

5

Further Content: You might find this interesting as well

Topics

BioNTechBiotech drugsmRNA technologyCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the U.S.
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu